
Expert analysis on coding updates, denial strategies, payer trends, and revenue optimization — written exclusively for dermatology practices.
MD fined Cigna $80K. 5-step playbook to protect your E/M revenue.
Electronic claims attachments required. 24-month compliance window.
Home visits, audio-only continue. But it's not permanent yet.
Triple the addressable market. Reimbursement may increase to $230.
Voice AI cuts calls 40%. ChatGPT interprets patient records. What to adopt.
Oral psoriasis biologic. Pharmacy benefit billing. PA implications.
Lawmakers push to halt WISER. BCBS reforms PA. California waives PAs approved 90%+ of the time.
New lipodystrophy, ulcer, abscess codes + xylazine wound category.
Four new CPT codes replace 77401, 0394T, G6001. Reimbursement may increase.
MAC processing errors causing telehealth denials. How to resubmit.
Fourth extension of controlled substance prescribing via telehealth.
Net ~0.8% increase. Skin substitutes reclassified. What it means for derm.
UHC cuts MA plans. ACA rates +25%. Cigna rebate-free PBM. AI claims review.
Complete checklist: ICD-10, CPT, SRT, skin substitutes, fee schedule.
When to use each modifier, documentation requirements, 2026 audit triggers, and the XS/XE alternatives.
The 90-day playbook: analyze, prevent, optimize. Cut your 14% denial rate in half.
CMS reclassified CTPs to incident-to supplies at $127/sq cm. 158 products delisted. Prior auth in 6 states.
POS 02 vs POS 10 vs POS 11 — stop the #1 cause of telehealth claim rejections with payer-specific workflows.
A comprehensive breakdown of the key CPT code revisions affecting dermatology — including updated destruction, biopsy, and Mohs codes.
Systematic appeal strategies that recover 89% of initially denied dermatology claims.
Stage-by-stage guidance on properly documenting and coding Mohs micrographic surgery.
A state-by-state breakdown of new prior authorization reform legislation for dermatology practices.
Analysis of shifting reimbursement rates across major commercial payers with contract negotiation strategies.
How PE-backed dermatology platforms can maintain billing performance during rapid growth and M&A integration.
Discover how much revenue your dermatology practice is leaving on the table. Our complimentary assessment identifies coding gaps, denial patterns, and collection opportunities.